This content is PDF only. Please click on the PDF icon to access.
Cost, distribution, and availability of health care have ceased to be matters of solely professional concern. Indeed, political decisions are becoming principal determinants of health policy. In an effort to bridge the gap between physicians and public planners, Drs. Weinstein and Stason have applied an appealing technique of cost-benefit analysis that describes the process and outcome of hypertensive care in economic terms.
Their model estimates benefit that might accrue under various circumstances if available antihypertensive technology were applied. The cost of treatment was extrapolated from available data to permit calculation of the real price of each added "quality-adjusted life year."
Hypertension. A Policy Perspective.. Ann Intern Med. ;87:135–136. doi: 10.7326/0003-4819-87-1-135
Download citation file:
Published: Ann Intern Med. 1977;87(1):135-136.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use